Among the phosphate-containing medicinal products prescribed to chronic kidney disease patients, 76% may contain absorbable phosphate.
Baseline eGFR, higher phosphorus, proteinuria, and male gender, also are associated with an elevated risk of end-stage renal disease in patients with chronic kidney disease.
Patiromer's efficacy and safety confirmed out to 52 weeks.
ECG Metrics are stronger as markers for cardiovascular death than for all-cause mortality or noncardiovascular death.
Study implicates an inability of a CKD patient's kidneys to excrete the daily acid load.
Older patients with more diabetes complications have greater cognitive decline, study finds.
Fracture rates are 2.4- to 3-fold higher than rates found in the general population of children and adolescents.
In a study, CKD was 35% more likely to develop in female than male diabetics in adjusted analyses that took into account death as a competing risk.
Proteinuria, hyperphosphatemia, anemia linked more rapid annual decline in eGFR.
CKD, which is mainly defined by laboratory abnormalities, is a suitable EHR phenotype.
Study reveals a 35% increase in all-cause mortality risk compared with non-use.
Treatment with this compound resulted in higher circulating levels of 25(OH)D compared with ergocalciferol in Hispanic CKD patients.
After standard lipid treatments, CKD patients still have up to a 70% residual risk of cardiovascular disease.
In a study, renal survival increased by 8.2% with each 10 nmol/L increment in baseline levels of 25-hydroxyvitamin D.
A study found that 78% of popular drinks, from flavored waters to lemonades to iced teas, contain far more phosphorus than listed in nutritional databases.
Increased uric acid levels were correlated with decreased HbA1c and increased prevalence of diabetic kidney disease, study finds.
Patients who use the supplements should have their kidney function and electrolytes monitored, researchers say.
AKI developed in bodybuilders who injected anabolic steroids and ingested commercial protein and creatine products.
The combination of eGFR and ACR outperformed most single traditional parameters for cardiovascular risk discrimination in patients with chronic kidney disease.
The magnitude of the increased risk was similar to that of having a previous cardiovascular event.
In a small study, each 1 mL/min/1.73 m2 decrease in eGFR was associated with a significant 0.020 mmol/L increase in serum sodium.
The association is particularly pronounced in younger patients with higher levels of proteinuria.
One-third of patients who missed clinical targets for phosphorus, calcium and/or parathormone remained untreated.
These findings underscore the need to better understand whether earlier phosphorus management influences morbidity and mortality in advanced CKD, according to researchers.
A significant proportion of children with chronic kidney disease (CKD) have unsuspected chromosomal imbalances.
Over 12 months, the exercise intervention increased participants' activity level by 2 or more metabolic equivalents.
Guidelines currently don't recognize gout as a risk factor for CKD and nephrolithiasis.
The incidence of gout among CKD patients was 6.82 per 1,000 persons per year compared to 2.43 for those without the disease.
Researchers compared 3 screening approaches for their ability to detect chronic kidney disease cases, and identify patients with higher rates of cardiovascular events and kidney decline.
Achieving an exercise capacity of more than 6.5 metabolic equivalents - such as daily brisk walking for 30-40 minutes -- might be protective, according to researchers.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)